Immunohistochemical analysis revealed a triple-negative profile, with the tumor cells lacking expressions of estrogen receptor (ER), progesterone receptor (PR), and HER2 (human epidermal growth factor receptor 2). This evidence concerns the gene ESR1 and neoplasm.